Hi, this is Sean Salai, culture reporter at The Washington Times.
We are out at the 53rd National March for Life, where we are interviewing pro-life leaders.
[SKOP] Thanks, Sean. I’m Dr. Ingrid Skop. I’m a board-certified OB-GYN from Texas, and I’m also the Director of Medical Affairs at the Charlotte Lozier Institute, doing research on issues related to life.
So we have one question for you today. What do you want to see from the Trump administration on the pro-life issue this year considering the changing landscape since the Dobbs ruling?
Well, I think it’s important for everyone to recognize that abortion drugs are off the rails, Mifepristone and Misoprostol. It’s no longer required to have an in-person visit before they’re prescribed. Women are ordering them online, and not just women. Abusive men are ordering them online. There’s no documentation of who’s ordering. They’re being delivered in the mail so often to pro-life states like Texas, and then women are having completely medically unsupervised abortion. No testing in advance, no follow-up.
Approximately one out of 20 women go to an emergency room with complications after taking these drugs. I’ve cared for many of them. It’s heartbreaking. There’s no one besides the ER that cares. And so that is happening. It’s injuring women physically. It’s injuring them emotionally because sometimes their experience lasts for months.
And we don’t even know what’s happening long term, what other future pregnancy complications might be happening, because really the data on abortion is terrible. There is nothing mandatorily collected on a federal level. So I just think we would need to get information out to people. And then those that are in charge of regulating Mifepristone hopefully can put those guardrails back on and protect women from these harms.
For more of our coverage of the March for Life, please visit washingtontimes.com.
